Delayed immune-related adverse events in long-responders of immunotherapy: a single-center experience.

Masatake KitanoTakayuki HondaEri HikitaMasahiro MasuoYasunari MiyazakiMasayoshi Kobayashi

Published in: Asia-Pacific journal of clinical oncology (2024)

PD-L1/PD-1 inhibitors frequently caused various irAEs but their severities were mostly tolerable. Few patients developed delayed irAE with mild toxities.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors